New clinical trials with vitamin D and analogs in renal disease | Zendy

Rajiv Kumar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

New clinical trials with vitamin D and analogs in renal disease

Author(s) -

Rajiv Kumar

Publication year - 2011

Publication title -

kidney international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.499

H-Index - 276

eISSN - 1523-1755

pISSN - 0085-2538

DOI - 10.1038/ki.2011.260

Subject(s) - medicine , clinical trial , disease , vitamin d and neurology , intensive care medicine

Two new clinical trials highlight refinements in the use of vitamin D and its analogs in the treatment of secondary hyperparathyroidism in end-stage renal disease (ESRD), and the treatment of proteinuria in diabetics. In patients with ESRD, alfacalcidol is as effective as paricalcitol in suppressing parathyroid hormone; the occurrence of hypercalcemia and hyperphosphatemia is infrequent and similar with the two analogs. Oral cholecalciferol reduces albuminuria and urinary transforming growth factor-β1 in patients with type 2 diabetes mellitus and proteinuria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research